[Federal Register Volume 62, Number 131 (Wednesday, July 9, 1997)]
[Notices]
[Page 36827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-17849]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Cooperative Agreements for Competitive 
Innovations in Syphilis Prevention in the United States: Reconsidering 
the Epidemiology and Involving Communities, Phase II: Evaluation of a 
Community Intervention, Program Announcement 523: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Disease, Disability, and Injury Prevention and Control 
SEP: Cooperative Agreements for Competitive Innovations in Syphilis 
Prevention in the United States: Reconsidering the Epidemiology and 
Involving Communities, Phase II: Evaluation of a Community 
Intervention, Program Announcement 523.
    Time and Date: 8:30 a.m.-5 p.m., August 12, 1997.
    Place: 11 Corporate Square Boulevard, Conference Room A, 
Atlanta, Georgia 30329.
    Status: Closed.
    Matters to be discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement 523.
    The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Associate Director for Management and 
Operations, CDC, pursuant to Pub. L. 92-463.
    Contact Person For More Information: John R. Lehnherr, Chief, 
Prevention Support Office, National Center for HIV, STD, and TB 
Prevention, CDC, M/S E07, 1600 Clifton Road, NE, Atlanta, Georgia 
30333, telephone 404/639-8025.

    Dated: July 2, 1997.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 97-17849 Filed 7-8-97; 8:45 am]
BILLING CODE 4163-18-P